Home / Drug shortages / Dexamethasone Sodium Phosphate Injection

Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/08/2019. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
76045-0210-10
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10)
Initial Posting
02/08/2019
Revised Date

Reason

Demand increase for the drug

FDA data resources